FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/09/036743 [Registered on: 22/09/2021] Trial Registered Prospectively
Last Modified On: 21/09/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   EFFICACY OF INTRATHECAL 0.5% HYBERBARIC BUPIVACAINE 5mg WITH FENTANYL 10mcg VERSUS 0.5% HYPERBARIC BUPIVACAINE 5mg WITH FENTANYL 20mcg ON LEVEL AND DEPTH OF ANAESTHESIA AND HEMODYNAMIC PARAMETERS IN PARTURIENTS UNDERGOING CESAREAN SECTION: A RANDOMISED STUDY 
Scientific Title of Study   EFFICACY OF INTRATHECAL 0.5% HYBERBARIC BUPIVACAINE 5mg WITH FENTANYL 10mcg VERSUS 0.5% HYPERBARIC BUPIVACAINE 5mg WITH FENTANYL 20mcg ON QUALITY OF ANAESTHESIA AND HEMODYNAMIC PARAMETERS IN PARTURIENTS UNDERGOING CESAREAN SECTION: A RANDOMISED STUDY 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR RAMYASHREE S 
Designation  POST GRADUATE MEDICAL STUDENT 
Affiliation  BANGALORE MEDICAL COLLEGE AND RESEARCH INSTITUTE 
Address  DEPARTMENT OF ANAESTHESIOLOGY, BANGALORE MEDICAL COLLEGE AND RESEARCH INTITUTE, KR ROAD, BANGALORE

Bangalore
KARNATAKA
560002
India 
Phone  9740499419  
Fax    
Email  drramyashree2012@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR RAMESH R 
Designation  ASSOCIATE PROFESSOR 
Affiliation  BANGALORE MEDICAL COLLEGE AND RESEARCH INSTITUTE 
Address  DEPARTMENT OF ANAESTHESIOLOGY, BANGALORE MEDICAL COLLEGE AND RESEARCH INTITUTE, KR ROAD, BANGALORE

Bangalore
KARNATAKA
560002
India 
Phone  9844837939  
Fax    
Email  rameshrevanna@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  DR RAMESH R 
Designation  ASSOCIATE PROFESSOR 
Affiliation  BANGALORE MEDICAL COLLEGE AND RESEARCH INSTITUTE 
Address  DEPARTMENT OF ANAESTHESIOLOGY, BANGALORE MEDICAL COLLEGE AND RESEARCH INTITUTE, KR ROAD, BANGALORE

Bangalore
KARNATAKA
560002
India 
Phone  9844837939  
Fax    
Email  rameshrevanna@yahoo.co.in  
 
Source of Monetary or Material Support  
BANGALORE MEDICAL COLLEGE AND RESEARCH INSTITUTE, KR ROAD, BANGALORE-560002 
 
Primary Sponsor  
Name  BANGALORE MEDICAL COLLEGE AND RESEARCH INSTITUTE 
Address  DEPARTMENT OF ANAESTHESIOLOGY, BANGALORE MEDICAL COLLEGE AND RESEARCH INSTITUTE, KR ROAD, BANGALORE - 560002 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
DR RAMESH R  DEPARTMENT OF ANAESTHESIOLOGY, BANGALORE MEDICAL COLLEGE AND RESEARCH INSTITUTE, KR ROAD, BANGALORE - 560002 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR RAMYASHREE S  BANGALORE MEDICAL COLLEGE AND RESEARCH INSTITUTE  DEPARTMENT OF ANAESTHESIOLOGY, BANGALORE MEDICAL COLLEGE AND RESEARCH INSTITUTE, KR ROAD, BANGALORE - 560002
Bangalore
KARNATAKA 
9740499419

drramyashree2012@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
BMCRI ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O82||Encounter for cesarean delivery without indication,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  0.5% HYPERBARIC BUPIVACAINE 5 mg WITH FENTANYL 10 mcg  INTRATHECAL INJECTION OF 0.5% HYPERBARIC BUPIVACAINE 5 mg WITH FENTANYL 10 mcg, TOTAL VOLUME TO BE MADE 2 ml BY ADDING NORMAL SALINE 
Comparator Agent  0.5% HYPERBARIC BUPIVACAINE 5 mg WITH FENTANYL 20 mcg  INTRATHECAL INJECTION OF 0.5% HYPERBARIC BUPIVACAINE 5 mg WITH FENTANYL 20 mcg, TOTAL VOLUME TO BE MADE 2 ml BY ADDING NORMAL SALINE 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  ASA CLASS II, AGED BETWEEN 18 TO 40 YEARS, POSTED FOR ELECTIVE CESAREAN SECTION 
 
ExclusionCriteria 
Details  PATIENTS REFUSAL
ALLERGIC TO DRUG
OBESE
ASA CLASS III OR IV
PRE ECLAMPSIA, ECLAMPSIA, CARDIAC OR RESPIRATORY INSUFFICIENCY, TWIN GESTATION
SEVERE FETAL DISTRESS, PLACENTAL ABRUPTION, PLACENTA PREVIA, CORD PROLAPSE
CONTRAINDICATIONS FOR NEURAXIAL BLOCKADE 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
QUALITY OF ANASTHESIA - LEVEL AND DEPTH OF SENSORY AND MOTOR BLOCKADE  BASELINE READING AND 1MIN AFTER SAB, 2MIN, 3MIN, 5MIN, 10MIN, 15MIN, 20MIN, 25MIN, 30MIN, 40MIN,50MIN, 60MIN, 75MIN, 90MIN, 105MIN, 120MIN, POSTOPERATIVELY HOURLY FOR 4 HOURS 
 
Secondary Outcome  
Outcome  TimePoints 
NO HEMODYNAMIC CHANGES OR SIDE EFFECTS  BASELINE READING AND 1MIN AFTER SAB, 2MIN, 3MIN, 5MIN, 10MIN, 15MIN, 20MIN, 25MIN, 30MIN, 40MIN,50MIN, 60MIN, 75MIN, 90MIN, 105MIN, 120MIN, POSTOPERATIVELY HOURLY FOR 4 HOURS 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   26/09/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NONE YET 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - For individual participant data meta-analysis.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [drramyashre2012@gmail.com].

  6. For how long will this data be available start date provided 26-07-2023 and end date provided 26-07-2026?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  

Regional Anaesthesia is the preferred technique during Lower Segment Cesarean Section. Bupivacaine is the most commonly used local anaesthetic agent in spinal anaesthesia. Opioids such as fentanyl are commonly used as intrathecal adjuvants to improve the quality of intraoperative analgesia and prolonged post-operative analgesia. 

The rapid onset of sympathetic blockade and subsequent hypotension remains a major clinical concern. Hypotension leads to nausea, vomiting and neonatal morbidity by reducing uteroplacental blood flow. Lowering the dose of intrathecal bupivacaine by using fentanyl as adjuvant can be used to maintain better hemodynamic stability, lesser requirement of vasopressors, provide better analgesia, reduced Post-Operative Nausea and Vomiting.

This study is undertaken to study the effect of Hyperbaric Bupivacaine 0.5% 5mg with fentanyl 10mcg vs of Hyperbaric Bupivacaine 0.5% 5mg with fentanyl 20mcg in spinal anaesthesia on hemodynamic changes, onset, level, duration and speed of regression of Sensory and Motor blockade in Parturients undergoing Lower Segment Caesarean Section.

Our study is Randomised Controlled study which will be conducted in Bangalore Medical College And Research Institute, Bangalore. It will be conducted on 100 participants, 50 in Hyperbaric Bupivacaine 0.5% 5mg with fentanyl 10mcg group and 50 in Hyperbaric Bupivacaine 0.5% 5mg with fentanyl 20mcg.

Intraoperatively Hemodynamic variables and level and depth of anaesthesia will be recorded every minute for first five minutes, at 5 minutes for next half an hour after the administration of subarachnoid block and every 10 minutes thereafter up to 120 minutes after the block. Postoperatively patient will be monitored every 1hr for the first 4hours. Side effects such as hypotension, bradycardia, shivering, nausea, vomiting, pruritis, respiratory depression and ECG changes will be recorded and accordingly managed.

 
Close